Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Brinar

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
European Journal of Neurology|October 26, 1999
Changes in short-term memory processes in patients with multiple sclerosisD Janculjak, Z Mubrin, Z Brzovic, et al.
Acta Medica Iugoslavica|January 1, 1977
[Correlation of serum gentamicin concentrations and its vestibular toxicity]B Vrhovac, V Brinar, T Tambić, et al.
The Neurologist|March 12, 2010
Primary diffuse meningeal melanomatosisIvana Zadro, Vesna V Brinar, Barbara Barun, et al.
Journal of the Neurological Sciences|September 18, 2008
Subacute brainstem angioencephalopathy: favorable outcome with anticoagulation therapyMario Habek, Svjetlana Supe, Zdravka Poljaković, et al.
The Journal of International Medical Research|February 12, 2011
A case of lichen ruber planus in a patient with familial multiple sclerosisJ Sepić, S Ristić, O Perković, et al.
Neurology|March 24, 2012
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trialA J Coles, E Fox, A Vladic, et al.
Neurology|September 4, 2016
Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MSDouglas L Arnold, Elizabeth Fisher, Vesna V Brinar, et al.
Lancet (London, England)|November 6, 2012
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trialJeffrey A Cohen, Alasdair J Coles, Douglas L Arnold, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
European Journal of Neurology|October 26, 1999
Changes in short-term memory processes in patients with multiple sclerosisD Janculjak, Z Mubrin, Z Brzovic, et al.
Acta Medica Iugoslavica|January 1, 1977
[Correlation of serum gentamicin concentrations and its vestibular toxicity]B Vrhovac, V Brinar, T Tambić, et al.
The Neurologist|March 12, 2010
Primary diffuse meningeal melanomatosisIvana Zadro, Vesna V Brinar, Barbara Barun, et al.
Journal of the Neurological Sciences|September 18, 2008
Subacute brainstem angioencephalopathy: favorable outcome with anticoagulation therapyMario Habek, Svjetlana Supe, Zdravka Poljaković, et al.
The Journal of International Medical Research|February 12, 2011
A case of lichen ruber planus in a patient with familial multiple sclerosisJ Sepić, S Ristić, O Perković, et al.
Neurology|March 24, 2012
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trialA J Coles, E Fox, A Vladic, et al.
Neurology|September 4, 2016
Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MSDouglas L Arnold, Elizabeth Fisher, Vesna V Brinar, et al.
Lancet (London, England)|November 6, 2012
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trialJeffrey A Cohen, Alasdair J Coles, Douglas L Arnold, et al.
Pageof 9